Navigation Links
Data Trol™ Abnormal Control Serum

ProductsData Trol™ Abnormal Control Serum
Company ThermoFisher Scientific
Item Data Trol™ Abnormal Control Serum
Features 
  • Data Trol™ Abnormal Control Serum is intended for monitoring the accuracy and precision of commonly used clinical chemistry assays.
  • It is for in vitro diagnostic use only.
  • Provided in a 10 x 5ml lyophilized format, the control offers up to ten days stability at 2 8°C once reconstituted.
Description Data Trol™ Abnormal Control Serum is intended for monitoring the accuracy and precision of commonly used clinical chemistry assays. It is for in vitro diagnostic use only. Provided in a 10 x 5ml lyophilized format, the control offers up to ten days stability at 2 8°C once reconstituted. The control is to be used in accordance with the directions accompanying the assay procedure being used. While following these directions, the control serum is to be treated in the same manner a patient specimen would be treated. The results obtained for the control are to be compared with the assigned values given in the Assay Data section of the insert. An Evaluation made by the standard statistical technique determines if the procedure is within control limits.
Info ThermoFisher Scientific
Customer Service: (800) 637-3717
Web site: http://www.thermofisher.com/global/en/home.asp

Related medicine products :

1. Data Trol™ Normal Control Serum
2. Genomic Microarray Analysis for Constitutional Abnormalities
3. Endoalpha Centralized O.R. Control System
4. Cruise Control
5. US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control
6. Fluid Control 2203
7. Flow Controller
8. Duet Diabetes Control System
9. Hemo_Control
10. Macro-Vue RPR (Rapid Plasma Reagin) Control Card
11. Macro-Vue RPR (Rapid Plasma Reagin) Control Cards
Hardy Nasal Bivalve Specula
Triad Facet Screws
Cushing Pituitary Spoons
...terior Spinal Implant system. Material that has a ...al bone. The result is an implant that meets the s... while optimizing the fusion environment through a...mic design with 5 and 10 degrees of lordosis. Mini...
Medicine Products:
(Date:11/8/2009)... 3D Global Solutions is plea...gram managing the proposal effort for ReSound who ...Digital Hearing Aid contract. The award includes n...Department of Defense and other federal agencies. ...vember 8, 2009 -- 3D Global Solutions is pleased t...
(Date:11/8/2009)..., "One victory does not mean the battle is won,"... 7 In a vote of 240-194...inski-Smith Amendment to prohibit abortion mandate.... ,, Americans United for Life Action President... this amendment is a victory for the pro-life Amer...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 T...Director, Operation Rescue Insurrecta Nex. ,, ...ry have been fighting to keep child-killing by abo..., Mr. Terry states: "This is a great first step to...t we have a lot of fighting ahead of us. Our rejoi...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 K...h Insurance Plans (AHIP), released the following s..., "Health plans strongly support comprehensive hea...iscussion by proposing a complete overhaul of how ...e proposed guaranteed coverage, elimination of pre...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling this a ...tion (AMA), the AMA President J. James Rohack, M.D...sicians from all state and medical specialty socie...y-making meeting, where health system reform will ...com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Over ...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...IRVINE, Calif., March 4 ISTA Pharmaceuticals,Inc.... fourth quarter 2007,financial results on March 6,...t a conference call, with a simultaneous webcast, ... and Canadian participants may,dial 866-831-6270; ...
...These flat growths are relatively common and tend ... March 4 (HealthDay News) -- While the majority of..., a new study challenges that assumption and point...he Journal of the American Medical Association r...
..., CHARLESTON, S.C. (March 4, 2008) In the curren...m from the Medical University of South Carolinas (... experience with a novel imaging technique that en... Powers, MD, medical director of MUSC Heart and Va...
...HARRISBURG, Pa., March 4 Governor Edward G.,Rende...t public support for,the Governor,s Cover All Penn...n of a tax increase on cigarettes and tobacco prod...mittee that continuing the Mcare abatement will he...
...PHILADELPHIA, March 4 Independence Blue Cross and...ladelphia announced today that,they have reached a...s,unusual in this market and a first in the histor...ital, serving the,special health care needs of chi...
...ALLEGAN, Mich., March 4 Perrigo Company,(Nasdaq: ...ipping 20 mg,Omeprazole delayed released tablets t...same medicine at the same dose as Prilosec OTC(R)....r-the-counter,market in the United States of the D...
Other Medicine News:Health News:Non-Polyp Colon Lesions Hard to Detect 2Health News:Non-Polyp Colon Lesions Hard to Detect 3Health News:Comprehensive diagnosis of heart disease with a single CT scan 2Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 2Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 3Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 4Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 2Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 3Health News:Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets 2Health News:Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets 3
(Date:11/6/2009)...PRNewswire/ -- Philips Respironics applauds the ef...ntion (CDC) to raise awareness about an important .... The CDC,s release of the first-ever government s...plessness is a milestone in quantifying the size a...cator, industry leader and sleep therapy manufactu...
(Date:11/6/2009)...e-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) ...cial results for the second quarter ended October ...on Wednesday, November 18, 2009 at 5:00 PM EST. T...ss those results on Thursday, November 19, 2009 at...ter Results Conference Call Instructions ,, T...
(Date:11/6/2009)...ewswire/ -- , - Trial Will Compare NXL103...nt of Multi-Resistant Staphylococcus Aureus (MRSA)...aceutical company focused on the discovery and,dev... the significant global,problem of microbial resis...,antibacterial NXL103 (flopristin/linopristin), ha...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Americas No 1 Pharmacy Names Great Health as Its Exclusive Health and Wellness Magazine 56168 1Rodgers Introduces SamarionSolution to International Audience 56164 1Rodgers Introduces SamarionSolution to International Audience 56164 2The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 1The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 2The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 3